A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer
Authors:
Open Access
- 20 July 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (7) , e0159115
Abstract
MicroRNA (miR)-143/145, known as tumor suppressors, can promote cell apoptosis and differentiation, and suppress cell proliferation, invasion and migration. We performed a case-control study to investigate the association of rs353293 in the promoter region of miR-143/145 with bladder cancer risk. In total, 869 subjects including 333 cases and 536 controls were enrolled in this study, and the rs353293 polymorphism was genotyped by using a Taqman assay. The promoter activity was measured by the Dual-Luciferase Assay System. We calculated an adjusted odds ratio of 0.64 for the presence of either AA/AG genotypes (95% CI 0.46–0.90) and 0.64 (95% CI 0.47–0.87) for carrying at least one A allele in bladder cancer. Stratified analyses showed that the AA/AG genotypes and the A allele were less prevalent in patients with low grade tumors, compared to those harboring higher grade bladder cancers (adjusted OR = 0.53, 95% CI, 0.30–0.94, P = 0.03 and adjusted OR = 0.54, 95% CI, 0.32–0.92, P = 0.02, respectively). In vitro luciferase reporter analysis showed that rs353293A allele had a lower activity compared with the rs353293G allele (P < 0.001). These findings suggest that the functional rs353293 polymorphism may be a useful biomarker to predict the risk of bladder cancer.Keywords
Funding Information
- Health and Family Planning Commission of Guangxi (Z2015085)
This publication has 37 references indexed in Scilit:
- MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancerMolecular Medicine Reports, 2013
- socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cellsCell Death & Disease, 2013
- Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathwaysCancer Letters, 2013
- miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2Molecular Medicine Reports, 2011
- The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerBritish Journal of Cancer, 2011
- Environmental factors and genetic susceptibility promote urinary bladder cancerToxicology Letters, 2010
- Identification of non-coding RNAs embracing microRNA-143/145 clusterMolecular Cancer, 2010
- miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in MicePLOS ONE, 2009
- MicroRNAsCell, 2004
- Familial aggregation of urothelial cell carcinomaInternational Journal of Cancer, 2001